Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |